1) To determine the quality of safe provision of cholecystectomy, including the rates of: (i) achieving a critical view of safety; (ii) intraoperative imaging use (e.g., cholangiogram); and (iii) initiating of different bailout procedures (e.g., subtotal cholecystectomy) when safe cholecystectomy is compromised.To assess adverse events following cholecystectomy (e.g., bile duct injury) and their management.

2) To assess adverse events following cholecystectomy (e.g., bile duct injury) and their management.

3) To analyse rates and outcomes of unsuspected gallbladder cancer.

4) To evaluate the global variation in the availability of cholecystectomy services and training amongst included hospitals.

We are extremely grateful for the World Society of Emergency Surgery in supporting the study

Key points about GECKO:

• Prospective, observational cohort study, with no changes to patient management
• All hospitals globally performing cholecystectomy can participate
• Data collection will be eight 2-week periods between August and December 2023
• All collaborators will be included as PubMed citable co-authors on resulting publications.

https://www.globalsurgeryunit.org/clinical-trials-holding-page/project-gecko/

Study protocol:

Register your hospital